按细胞学、人乳头瘤病毒16/18型和阴道镜印象分层预测宫颈上皮内瘤变2级或更差风险:系统评价与Meta分析
该系统评价与Meta分析检索PubMed与ClinicalTrials.gov,纳入9项已发表研究及3项未发表研究数据,按细胞学结果、HPV16/18基因型和阴道镜印象组合计算宫颈上皮内瘤变2级或更差及3级或更差的汇总风险。结果显示不同研究中最低风险组风险模式相似,阴道镜印象正常(无醋酸白)、细胞学低于高级别鳞状上皮内病变且HPV16/18阴性者癌前病变风险低;具备高级别鳞状上皮内病变细胞学、HPV16或18阳性、高级别阴道镜印象中至少两项者癌前病变风险最高。结论支持基于风险的阴道镜与活检方法,在最低和最高风险水平调整实践。
要点
- 阴道镜印象正常、细胞学低于高级别鳞状上皮内病变且HPV16/18阴性者癌前病变风险低。
- 具备高级别鳞状上皮内病变细胞学、HPV16或18阳性、高级别阴道镜印象中至少两项者癌前病变风险最高。
- 不同研究中最低风险组风险模式相似,支持基于风险分层的阴道镜与活检实践。
核心结论
- 结果支持基于风险的阴道镜与活检方法,并在最低和最高风险水平调整实践。
研究设计与样本
- 系统评价与Meta分析,检索PubMed(2016年6月1日)和ClinicalTrials.gov(2018年6月9日)。
- 纳入标准为包含阴道镜印象及细胞学结果或HPV16/18部分基因型结果,并有组织学活检诊断的成人女性研究。
- 共识别340篇摘要,9项符合纳入标准;另获取3项未发表研究数据,其中2项此后已发表。
主要发现
- 按细胞学、阴道镜和HPV16/18检测结果计算宫颈上皮内瘤变2级或更差及3级或更差的风险。
- 不同研究中最低风险组风险模式相似,尽管转诊人群和研究设计不同,风险估计相似。
- 阴道镜印象正常(无醋酸白)、细胞学低于高级别鳞状上皮内病变且HPV16/18阴性者癌前病变风险低。
- 具备高级别鳞状上皮内病变细胞学、HPV16或18阳性、高级别阴道镜印象中至少两项者癌前病变风险最高。
临床怎么用
- 原文未据此给出具体推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To calculate pooled risk estimates for combinations of cytology result, human papillomavirus (HPV) 16/18 genotype and colposcopy impression to provide a basis for risk-stratified colposcopy and biopsy practice. DATA SOURCE: A PubMed search was conducted on June 1, 2016, and a ClinicalTrials.gov search was conducted on June 9, 2018, using key words such as "uterine cervical neoplasms," "cervical cancer," "mass screening," "early detection of cancer," and "colposcopy." METHODS OF STUDY SELECTION: Eligible studies must have included colposcopic impression and either cytology results or HPV 16/18 partial genotype results as well as a histologic biopsy diagnosis from adult women. Manuscripts were reviewed for the following: cytology, HPV status, and colposcopy impression as well as age, number of women, and number of cervical intraepithelial neoplasia (CIN) 2, CIN 3, and cancer cases. Strata were defined by the various combinations of cytology, genotype, and colposcopic impression. TABULATION, INTEGRATION, AND RESULTS: Of 340 abstracts identified, nine were eligible for inclusion. Data were also obtained from three unpublished studies, two of which have since been published. We calculated the risk of CIN 2 or worse and CIN 3 or worse based on cytology, colposcopy, and HPV 16/18 test results. We found similar risk patterns across studies in the lowest risk groups such that risk estimates were similar despite different referral populations and study designs. Women with a normal colposcopy impression (no acetowhitening), less than high-grade squamous intraepithelial lesion cytology, and HPV 16/18-negative were at low risk of prevalent precancer. Women with at least two of the following: high-grade squamous intraepithelial lesion cytology, HPV16- or HPV18-positive, and high-grade colposcopic impression were at highest risk of prevalent precancer. CONCLUSION: Our results support a risk-based approach to colposcopy and biopsy with modifications of practice at the lowest and highest risk levels.
引用
- Silver MI, Andrews J, Cooper CK, et al. Risk of Cervical Intraepithelial Neoplasia 2 or Worse by Cytology, Human Papillomavirus 16/18, and Colposcopy Impression: A Systematic Review and Meta-analysis. Obstet Gynecol. 2018. PMID: 30095780. doi:10.1097/AOG.0000000000002812
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。